Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...

PharmEd Randolph


 
        December 7, 2017 - Thursday 
 
       Lombardo's Conference Center
       6 Billings Street
       Randolph, MA  02368
 
      
 
 
 
A one-day professional conference that offers pharmacists a source of CE credits, pharmacy product information, networking opportunities and gives pharmacists access to cutting edge information. Continental breakfast, lunch and afternoon refreshments will be served. 
 
 
Please note, handouts will not be available the day of the PharmEd/Clinical Update conferences.  You may download & print, or save a PDF of the handouts to your laptop, tablet or other device. You must be registered for the conference to download the handouts directly from our website by logging in and clicking on the event. The handouts will become available 3 to 5 days before each conference.
 

 

Date: Dec 7, 2017 08:00 AM - 05:00 PM

Fee

$119.00

CE Hours

7.00

CE Units

0.700

Registration closes on Dec 06, 2017 11:00 PM

Target Audience(s)

  • Pharmacists

Accreditation(s)

Accreditation Council for Pharmacy Education
American Health Resources is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education

Requirements for CE Credit

  • Participant Requirement and Statement of Credit: To receive credit, participants must fully attend each session (no partial credit will be awarded), pass in a completed attendance verification form, and using the access code provided, complete the online evaluation for each session attended. Attendance will be verified. All participants will have the opportunity to evaluate the educational sessions and presenters as well as the ability to identify their future educational needs. 
  • Pharmacists: CE credit will be automatically uploaded to CPE Monitor upon completion of the evaluation and posted to the participant’s NABP account within 72 hours where an official certificate of credit can be printed. Evaluations must be completed within 60 days of program date to receive credit.  
  • Statement of Disclosure: Disclosure will be made on the day of the program regarding any interest or affiliation a speaker may have with a supporting organization.
  • Refund Policy: A full refund will be provided only if a written request is received by American Health Resources, Inc. at least 48 hours prior to the program or if the program is cancelled. American Health Resources, Inc. reserves the right to change the presenters, topics or seminar schedules.
Only Certificates of Credit issued from CPE Monitor are valid in the US. 
CPE Monitor will not accept credits after 60 days from the session date.

Support/Credits

Supported by Independent Educational Grant from: Boehringer Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC.
 
Educational Supporter:  New England AIDS Education and Training Centers 
   

 

 

 

   

This activity will educate pharmacists about the nature of addiction with emphasis on opioids as both a case example and a current crisis in addiction and public health. Participants will learn the current trends in opioid abuse and addiction along with common symptoms and comorbidities in this population.  The presentation will also review pharmacologic treatments for opioid addiction and overdose, as well as the role of pharmacists in preventing and recognizing substance use disorders, and providing support to treatment for people with substance use disorder.
Knowledge Based

Objectives

  • Discuss current theories about the nature of addiction and the roots of our current opioid epidemic.
  • Identify common non-controlled substances that are used in street “cocktails” to enhance or modify opioid effects.
  • Describe the role of buprenorphine, naltrexone and methadone for addiction treatment.
  • Explain the efficacy and effectiveness of naloxone and the importance of pharmacists in stopping overdoses.
  • Recognize the distinction between trust and patient-centeredness, in order to build healing relationships with people we may not trust.

Speaker(s)/Author(s)

Joseph Wright, MD, AAHIVS picture

Joseph Wright, MD, AAHIVS
Internal Medicine, Boston Healthcare for the Homeless Program, Boston Healthcare for the Homeless Program

Activity Number

0280-9999-17-092-L01-P
Date: 12/07/17
Time: 08:30 AM - 10:00 AM

CE Hours

1.50
   

   

The American College of Cardiology and the American Heart Association released their most recent guidelines for management of blood cholesterol to reduce atherosclerotic cardiovascular risk in 2013. This presentation will give an overview of the updated guidelines, make comparisons to the most recent European guidelines, and review the most recent evidence for the newest class of lipid-lowering agents, the PCSK9 inhibitors.
Application Based

Objectives

  • Examine the most recent research-based evidence of lipid-lowering therapies and relate to patient cases.
  • Evaluate therapeutic options available for cholesterol management to lower cardiovascular risk.
  • Apply current practice guidelines to patient cases to determine best course of treatment.

Speaker(s)/Author(s)

Bryan Cook,  picture

Bryan Cook, , PharmD, BCPS
Clinical Pharmacy Specialist, Brigham and Women's Hospital


Brief Bio : Clinical Pharmacy Specialist, Cardiology & Critical Care Brigham & Women's Hospital; Affiliate Clinical Assistant Professor Northeastern University School of Pharmacy

Activity Number

0280-0000-17-093-L01-P
Date: 12/07/17
Time: 10:30 AM - 12:00 PM

CE Hours

1.50
   

   

This activity is designed to educate pharmacists to assist patients in managing their type 2 diabetes.  The activity will begin with an overview of the most recent guidelines from the American Diabetes Association (ADA) and American Association of Clinical Endocrinologists (AACE).  Goals and treatment algorithms for glycemic control will be compared.  Particular attention will be paid to the pharmacokinetic and pharmacodynamic profiles of basal insulins, SGLT2 inhibitors, DPP4 inhibitors, and GLP-1 receptor agonists.  Their role within the guidelines and especially combination therapy will be discussed.  An important component of the presentation will be case study review to illustrate drug selection and dosing for optimal glucose control and A1C reduction based on patient factors.  Studies have demonstrated the positive effects of pharmacist-directed medical management on glycemic control and treatment adherence.
Application Based
Original offering in Cromwell, CT on October 3, 2017, also offered in Westford, MA on November 7, 2017  If you receive credit for either of those activities you should not claim credit for this seminar. 

Objectives

  • Compare, contrast and apply newly released American Diabetes Association and American Association of Clinical Endocrinologists guidelines for glycemic management in patients with type 2 diabetes.
  • Describe the pharmacokinetic and pharmacodynamic differences of the SGLT-2 inhibitors, GLP-1RAs, DPP4 inhibitors, and basal insulins, and their roles within the guidelines.
  • Evaluate current data of combination therapy, including fixed-ratio agents, based on efficacy, dosage form, and complementary actions.
  • Utilizing patient cases, formulate evidence-based treatment regimens that optimize both fasting and post-prandial glucose and A1C reduction.

Speaker(s)/Author(s)

Jennifer Goldman, PharmD, CDE, BC-ADM, FCCP picture

Jennifer Goldman, PharmD, CDE, BC-ADM, FCCP
MCPHS University


Brief Bio : Dr. Goldman has been a pharmacist for over 20 years and joined the faculty at MCPHS University in 1997. She is a Professor of Pharmacy Practice and coordinates and teaches in various therapeutics courses. She has maintained a practice in primary care and family medicine with a specialty in diabetes and cardiovascular disease since 1997 and currently takes students on rotation at Well Life Medical in Peabody, MA where she practices as a clinical pharmacist and certified diabetes educator (CDE). She is on state-wide and national organizational committees and boards including but not limited to The Massachusetts Adult Diabetes Guidelines Working Group for the Diabetes Prevention and Control Program at the Department of Public Health in Massachusetts. She has been the recipient of the Long Term Service, Trustees Award for Teaching Excellence, The Preceptor of the Year, and the Pharmacy Practice Teacher of the year at MCPHS University and has been recognized by the American Academy of Family Physicians for teaching in Family Medicine. Her primary research interests are in the areas of diabetes, cardiovascular disease and teaching.

Activity Number

0280-0000-17-081-L01-P
Date: 12/07/17
Time: 01:00 PM - 03:00 PM

CE Hours

2.00
   

   

This session will summarize differences between legislation and regulations, review current regulations and proposed changes, review compliance techniques for medication packaging and describe common deficiencies found by investigators so that participants will be aware and know how to avoid them.    
Knowledge Based (LAW) 
 

Objectives

  • 1. Summarize the differences between legislation and regulations.
  • 2. Differentiate between proposed and current regulations.
  • 3. Describe proper compliance techniques for medication specialty packaging.
  • 4. Describe the common deficiencies found by investigators during pharmacy compliance inspections.

Speaker(s)/Author(s)

Julienne Tran, PharmD picture

Julienne Tran, PharmD


Brief Bio : Pharmacy Investigator, Massachusetts Board of Registration in Pharmacy
Michelle Chan, RPh picture

Michelle Chan, RPh


Brief Bio : Quality Assurance Pharmacist, Massachusetts Board of Registration in Pharmacy

Activity Number

0280-0000-17-094-L03-P
Date: 12/07/17
Time: 03:00 PM - 05:00 PM

CE Hours

2.00